Nothing less than a cure for cancer is in the sights of immune medicine pioneer, Adaptive Biotechnologies. But first the business is aiming for profitability, says CFO Tycho Peterson.
Watch video
Get the latest insights and news from RBC Capital Markets delivered to your inbox.